Thurston, Springer, Miller, Herd & Titak, Inc. Moderna, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $46.2 Million
- Q3 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 100 shares of MRNA stock, worth $2,477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 169
40.83%
Holding current value
$2,477
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MRNA
# of Institutions
847Shares Held
260MCall Options Held
37.9MPut Options Held
37M-
Vanguard Group Inc Valley Forge, PA41.2MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$633 Million0.07% of portfolio
-
Baillie Gifford & CO21.8MShares$541 Million0.44% of portfolio
-
State Street Corp Boston, MA17.1MShares$424 Million0.02% of portfolio
-
Morgan Stanley New York, NY9.96MShares$247 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.69B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...